Loading...
•
Dec 31, 2022
AbCellera Q4 2022 Earnings Report
AbCellera reported its Q4 2022 earnings, highlighting a net loss and revenue contribution from royalties and research fees.
Key Takeaways
AbCellera's Q4 2022 saw revenue of $21.5 million, with $9.5 million from royalties and $11.4 million from research fees. The company experienced a net loss of $29.9 million, or ($0.10) per share.
Total revenue for Q4 2022 was $21.5 million.
Royalties from bebtelovimab contributed $9.5 million to Q4 revenue.
Research fees generated $11.4 million in Q4.
Net loss for Q4 was $29.9 million, or ($0.10) per share.
Revenue by Segment
Forward Guidance
No specific forward guidance was provided in the press release.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...